HIP targets illiquid secondaries in private equity spend

The $560 million Health Industry Plan (HIP) has doubled its commitment to private equity by awarding mandates to managers targeting illiquid secondaries.

The fund has assigned $40 million collectively to US firm HarbourVest and Swiss alternatives outfit Partners Group, to acquire assets offered through private equity secondaries markets. The rationale for targeting the secondaries sector was that many owners of sound unlisted assets are under pressure to sell holdings to release some liquidity or, as some rich family-oriented European businesses enter succession phases, there are instances where young inheritors of these businesses are willing to sell some or all of their stakes, Ross Bernays, HIP chief executive officer, said. The mandates provide a significant boost to HIP’s private equity exposure: “in total commitments, they double it,” Bernays said. The fund for workers in the health and associated industries also recently appointed Craig Farr as its compliance officer from Sydney law firm De Grants. Farr’s previous tenures were at Colonial First State, Tower and Schroders, Bernays said.

, , , , , , , , , , ,

Leave a Comment

How Cbus built its new Australian equity strategy from scratch

Ryan Riedler, head of ASX core strategy, Australian equities at Cbus, says the fund will look to generate alpha locally through engagement and that internalisation will help it strengthen its connection with other market participants, as well as its brokers and service providers.

Sort content by

Previous